65,437 trials
Healthy Volunteers
Primary: Study 1, AUClast: Area Under the Plasma Concentration-time Curve From Time 0 to the Time of the Last Quantifiable Concentration for Free Base of TAK-438 (TAK-438F)…
Bariatric Surgery Analgesia
Primary: Fentanyl PCA mcg — 351.4; 360.7; 353.9 Micrograms
Diabetic Foot Ulcer
Primary: Clinical Cure — 38; 39 participants
Sialorrhea
Primary: Occurrence, Seriousness, Severity, and Causality Assessment of Treatment Emergent Adverse Events (TEAE) — 7; 14; 3; 2 participants
Aphasia · Stroke
Primary: Change From Baseline in Philadelphia Naming Test Score — 5.91 score on a scale — p=<0.005
Gastrointestinal Cancer
Primary: Serious Adverse Events — 0 Participants
Chronic Rhinitis
Primary: Change From Baseline in Symptom Severity — -3.1 score on a scale — p=<0.001
Candidiasis · Vaginosis, Bacterial
Primary: Change in the Presence of Vaginitis Clinical Symptoms Determined by Sobel Score. — 1.13; 1.21; 0.18; 0.22 score on a scale
HIV-1 Infection
Primary: Percentage of Participants With Human Immunodeficiency Virus-1 Ribonucleic Acid (HIV-1 RNA) < 50 Copies/mL at Week 12 as Defined by Pure Virologic Response (PVR)…
Astigmatism
Primary: Uncorrected Monocular Distance Visual Acuity — 0.14 logMAR
Breast Cancer
Primary: Percentage of Participants Who Achieved a Best Response of Complete Response, Partial Response, and Stable Disease (CR+PR+SD) (Clinical Benefit Rate) — 43.6; 43.6; 43.6…
Ventral Incisional Hernia
Primary: Incidence of Peri-operative and Post-operative Complications — 0; 1; 0 Participants
Pain Due to Intrauterine Contraceptive Device
Primary: Pain With Intrauterine Device (IUD) Placement — 54; 33 mm
Sepsis
Primary: ICU-free Days to 14 Days After Enrollment — 9; 11 days
Healthy
Primary: Flow Mediated Dilatation — 4.4; 3.9; 3.4; 4.4 metre — p=0.5